D
Dynavax Technologies Corporation (DVAX)
NMS – Real vaqt narxi. Valyuta: USD
15.50
0.00 (0.00%)
Bozor ochiq: Feb 10, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
15.50
0.00 (0.00%)
Bozor ochiq: Feb 10, 2026, 4:00 PM EDT
Dynavax Technologies Corporation, tijoriy bosqichdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlar va xalqaro miqyosda vaktsinalarni ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniya 18 yosh va undan katta yoshdagi kattalar uchun barcha ma'lum bo'lgan gepatit B virusi subtiplari keltirib chiqaradigan infektsiyaning oldini olish uchun gepatit B vaksinasi bo'lgan HEPLISAV-B; va HEPLISAV-Bda ishlatiladigan adjuvant bo'lgan CpG 1018ni taklif etadi. Shuningdek, u 2-fazali klinik sinovda bo'lgan o'latga qarshi vaksina nomzodi rF1V; va 50 yosh va undan katta kattalarda bel belanchasi (shingles) ning oldini olish uchun 1/2-fazali klinik sinovda bo'lgan tadqiqotdagi vaksina nomzodi Z-1018, shuningdek, gemodializdagi kattalar uchun HEPLISAV-Bni ishlab chiqmoqda. Kompaniya o'z mahsulotlarini gospitallar va klinikalarga, integratsiyalashgan etkazib berish tarmoqlariga, davlat sog'liqni saqlash klinikalari va qamoqxonalarga, Mudofaa vazirligiga, Faxriylar ishlari vazirligiga va chakana dorixonalariga ulgurji savdogarlar va maxsus distribyutorlar orqali sotadi. U AQSh Mudofaa vazirligi; Epidemiyaga tayyorgarlikni rag'batlantirish koalitsiyasi; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; va Biological E. Limited bilan hamkorlik shartnomasiga ega. Kompaniya ilgari Double Helix Corporation nomi bilan tanilgan va 1996 yil sentyabr oyida Dynavax Technologies Corporation nomini olgan. Dynavax Technologies Corporation 1996 yilda ro'yxatga olingan va Kaliforniyaning Emervil shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. David F. Novack | Senior VP & COO |
| Mr. John L. Slebir Esq. | Senior VP & General Counsel |
| Mr. Ryan Spencer | CEO & Director |
| Ms. Kelly MacDonald CPA | Senior VP & CFO |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-02-20 | 15-12G | d96766d1512g.htm |
| 2026-02-10 | SC TO-T/A | d12825dsctota.htm |
| 2026-02-10 | S-8 POS | d140298ds8pos.htm |
| 2026-02-02 | SC 14D9/A | d18668dsc14d9a.htm |
| 2026-01-30 | SC 14D9/A | d631851dsc14d9a.htm |
| 2026-01-28 | SC 14D9/A | d82219dsc14d9a.htm |
| 2026-01-12 | SC 14D9 | d929738dsc14d9.htm |
| 2025-12-29 | SC TO-C | d48726dsctoc.htm |
| 2025-11-05 | 10-Q | dvax-20250930.htm |
| 2025-10-16 | 8-K | d40644d8k.htm |